Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

This study has been completed.

Sponsor:

Collaborator:

Novartis Vaccines

Information provided by:

Novartis

ClinicalTrials.gov Identifier:

NCT00956761

First received: August 8, 2009

Last updated: August 10, 2009

Last verified: August 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)